Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Granules India arm gets USFDA nod for Gout flares drug Colchicine

Ruchika Sharma30 April 2024 11:30 AM IST

Colchicine Capsules are indicated for prophylaxis of gout flares in adults.

Gland Pharma appoints Satnam Singh Loomba as COO, Senior Management Personnel

Ruchika Sharma29 April 2024 3:55 PM IST

Telangana: Gland Pharma has appointed Satnam Singh Loomba as Chief Operating Officer (COO); a Senior Management Personnel of the Company,...

Gland Pharma profit rises 12 percent to Rs 184 crore in Q2

Gland Pharma bags USFDA nod for Cetrorelix Acetate for Injection

Ruchika Sharma29 April 2024 3:06 PM IST

Cetrorelix Acetate for Injection is used to prevent premature LH surges in women undergoing controlled ovarian stimulation.

Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead of schedule: Suven Life Sciences

India becoming attractive for clinical trials: Pharma industry leaders

Ruchika Sharma29 April 2024 2:33 PM IST

New Delhi: Experts from the pharmaceutical sector have noted that over the last decade, clinical trials in India have undergone significant...

Vice President Dhankhar visits Bharat Biotech facilities at Hyderabad

Ruchika Sharma29 April 2024 12:13 PM IST

Hyderabad: The Honourable Vice President of India, Jagdeep Dhankhar has paid a visit to facilities of Bharat Biotech located at Genome Valley,...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

JnJ gets positive CHMP opinion for Rybrevant, chemotherapy combo for first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations

Ruchika Sharma28 April 2024 12:30 PM IST

Belgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...

Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for recurrent genital herpes

USFDA approves Biktarvy label update with data for pregnant adults with HIV: Gilead Sciences

Ruchika Sharma28 April 2024 11:30 AM IST

Foster City: Gilead Sciences, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved an updated label with additional data...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

EMA Committee recommends nod for Bristol Myers Squibb Opdivo in combination with Cisplatin, Gemcitabine for Urothelial Carcinoma

Ruchika Sharma28 April 2024 11:30 AM IST

Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic gets USFDA approval for Inceptiv closed-loop spinal cord stimulator for chronic pain

Ruchika Sharma27 April 2024 4:59 PM IST

Dublin: Medtronic plc, a global leader in healthcare technology, has announced that the U.S. Food and Drug Administration (FDA) has approved the...

Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans Appeal

USFDA nod to Pfizer Beqvez for adults with Hemophilia B

Ruchika Sharma27 April 2024 12:09 PM IST

New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ (fidanacogene elaparvovec-dzkt) for the...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Zydus Lifesciences bags USFDA nod for acne cream Tretinoin

Ruchika Sharma27 April 2024 11:39 AM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...

AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment

AstraZeneca Voydeya approved in EU as add-on treatment to ravulizumab or eculizumab for adults with PNH who have residual haemolytic anaemia

Ruchika Sharma26 April 2024 4:10 PM IST

AstraZeneca has announced that Voydeya (danicopan) has been approved in the European Union (EU) as an add-on to ravulizumab or...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok